Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 2, 2007, Pages 104-108

  Cruz, Antonio Augusto Velasco ^a   Akaishi, Patrícia Mitiko Santello ^a   Vargas, Márcia Abelin ^a   De Paula, Sheila A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; STEROID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CHILD; CONTROLLED STUDY; DIPLOPIA; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VISUAL FIELD; VISUAL FIELD DEFECT; VITILIGO;

ADULT; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAVES OPHTHALMOPATHY; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 34247159923     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e318030b06b     Document Type: Article

References (31)

1. Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 1995;119:792-795.
2. Burch HB, Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993;14:747-93.
3. Reichlin M. Undifferentiated connective tissue diseases, overlap syndromes, and mixed connective tissue diseases. In: Arthritis and allied conditions. Koopman W (Ed.) Baltimore: Williams & Wilkins; 1997:1309-18.
4. Chen Q, Kukreja A, MacLaren N. Classification of the autoimmune polyglandular syndromes. In: Immunologically mediated endocrine diseases. Gill R, Harmon J, MacLaren N (Eds.) Philadelphia: Lippincott Williams & Wilkins; 2002:167-87.
5. Dittmar M, Kahaly G. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metabol 2003;88:2983-92.
6. Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002;12:977-988.
7. Jacobson DL, Gange SJ, Rose RR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinl Immunol Immunopathol 1997;84:223-43.
8. Levin L, Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev 2003;2:377-86.
9. Kusuhara T, Nakajima M, Imamura A. Ocular myasthenia gravis associated with euthyroid ophthalmopathy. Muscle Nerve 2003;28:764-66.
10. Kalmann R, Mourits MP. Diabetes mellitus: a risk factor in patients with Graves' orbitopathy. Br J Ophthalmol 1999;83:463-5.
11. Roitt I, Brostoff J, Male D. Autoimmunity and autoimmune disease. In: Immunology, 5th ed. Roitt I, Brostoff J, Male D (Eds.) London: Mosby-Wolfe; 1998:367-79.
12. Cooper G, Stroehla B. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119-25.
13. Broadley SA, Deans J, Sawcer SJ, et al. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 2000;123:1102-11.
14. Davis B, Devendra D, Liu E, Eisenbarth G. Type I diabetes: recent developments. BMJ 2004;328:750-4.
15. Alkhateeb A, Fain P, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14.
16. Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology 1991;3:89-91.
17. Ochi Y, DeGroot L. Vitiligo in Graves' disease. Ann Intern Med 1968;71:935-40.
18. Weetman A, Cohen S, Gatter K, et al. Immunohistochemical analysis of retrobulbar tissue in Graves' ophthalmopathy. Clin Exp Immunol 1989;75:222-7.
19. Van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000;80:1299-309.
20. Prummel MF, Wiersinga WM, Van der Gaag R, et al. Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clin Exp Immunol 1992;88:405-9.
21. Caixia T, Hongwen F, Xiran L. Levels of soluble interleukin-w receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci 1999;21:59-62.
22. Yeo U, Yang Y, Park K, et al. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients. J Dermatol Sci 1999;19:182-8.
23. Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 1992;128:702.
24. Safavi K, Muller S, Suman V, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1999;70:628-33.
25. Alexis A, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol 2004;14:364-70.
26. Tobin DJ. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Invest Dermatol Symp Proc 2003;8:176-81.
27. Zöller M, McElwee K, Vitacolonna M, Hoffmann R. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J Autoimmun 2004;23:241-56.
28. Grandhe N, Kanwar A. Alopecia areata of eyelash: a subset of alopecia areata. Dermatol Online J 2004;10:13.
29. Puavilai S, Puavilai G, Charuwichitratana S, et al. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994;33:632-3.
30. Tan E, Yong-Kwang T, Goh C, Giam Y. The pattern and profile of alopecia areata in Singapore - a study of 219 Asians. Int J Dermatol 2002;41:748-53.
31. Duvic M, Nelson A, Andrade M. The genetics of alopecia areata. Clin Dermatol 2001;19:135-9.